《新股消息》據報商湯科技將暫停香港IPO
《路透》引述消息人士報道,在被美國列入投資黑名單後,商湯科技(00020.HK)將於今日(13日)公佈暫停在香港的IPO,並會更新其招股說明書中的風險因素,以重新啓動IPO流程。
另外《彭博》亦知情人士報道,商湯正與其顧問合作,更新在香港IPO的招股說明書,以推進計劃中的上市。目前準備工作正在進行中,不過IPO可能面臨進一步推遲。
商湯科技是次在港上市最高集資額59.85億元,入場費爲4,030.2元,原定於上週五(10日)定價,本週五(17日)掛牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.